ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print January 22, 2009, 10.1183/09031936.00084608
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
33/6/1403    most recent
09031936.00084608v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacRedmond, R.
Right arrow Articles by Dorscheid, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacRedmond, R.
Right arrow Articles by Dorscheid, D. R.
Eur Respir J 2009; 33:1403-1414
Copyright ©ERS Journals Ltd 2009

Erythropoietin inhibits respiratory epithelial cell apoptosis in a model of acute lung injury

R. MacRedmond, G. K. Singhera and D. R. Dorscheid

Providence Healthcare Heart and Lung Institute, St Paul’s Hospital, University of British Columbia, Vancouver, BC, Canada.

CORRESPONDENCE: R. MacRedmond, Critical Care Research Group, Room #166, 1081 Burrard St, St Paul’s Hospital, Vancouver, BC, Canada V6Z-1Y6. Fax: 1 6048068351. E-mail: rmacredmond{at}mrl.ubc.ca

Keywords: Acute respiratory distress syndrome, critically ill, Fas/Fas-ligand, polymorphonuclear cells

Received: June 4, 2008
Accepted December 21, 2008

Fas-mediated apoptosis of the alveolar epithelium is important in the pathogenesis of acute respiratory distress syndrome. Erythropoietin (EPO) has cytoprotective properties in other organ systems, and is relatively deficient in critical illness. This study investigates a potential role for EPO in reducing apoptosis in a model of acute lung injury.

Apoptosis was induced in human alveolar epithelial (A549) cells or normal human bronchial epithelial (NHBE) cells by Fas activation with CH-11 Fas-crosslinking antibody or by co-culture with polymorphonuclear neutrophils in a transwell system. The effect of recombinant human (rh)EPO on apoptosis was measured by poly(ADP-ribose) polymerase cleavage and cell death detection assay. The specific EPO–EPO receptor (EPOR)-mediated effect was determined using an EPO-blocking antibody or EPOR small interfering RNA.

Expression of EPOR was demonstrated in A549, NHBE and normal human alveolar epithelium. Fas- and neutrophil-mediated apoptosis of A549 and NHBE cells was inhibited by rhEPO by a specific EPO–EPOR-mediated mechanism. This anti-apoptotic effect was associated with induction of a pro-apoptotic Bcl-xL/Bax ratio.

EPO has cytoprotective properties in respiratory epithelium in an in vitro model, which may indicate a potential therapeutic role in acute lung injury.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.